跳至主要内容
临床试验/NCT00689013
NCT00689013已完成不适用

The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

University of Tennessee6 个研究点 分布在 1 个国家目标入组 205 人开始时间: 2008年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
205
试验地点
6
主要终点
To assess the effect of a pharmacist-driven immunization campaign on the rate of Zostavax immunizations in three separate community pharmacy settings

研究概览

简要总结

The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.

详细描述

Several studies exist documenting the perception and satisfaction of patients receiving immunizations from pharmacists, as well as the effects of pharmacist involvement in advocating and administering vaccinations. The most well documented studies have been conducted in hospital settings. Undoubtedly, there is enormous opportunity for the community pharmacist to identify potential vaccine recipients, advocate immunization and administer said immunizations to their established patient populations. However, there is a lack of concentrated study in the implementation of immunization services in the community setting and their effects. The investigators intend to evaluate the intervention of pharmacists in an immunization program and the resulting changes in immunization rates.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Prevention
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • men and women aged 60 or older without contraindications for the herpes zoster vaccination
  • patients who have already experienced one or more episodes of herpes zoster infection were considered for vaccine receipt and study inclusion secondary to CDC ACIP recommendations

排除标准

  • Patients aged < 60 years
  • Anyone who has previously received the herpes zoster vaccine
  • Anyone with an allergy to neomycin, gelatin or any other component of the vaccine
  • Anyone receiving a live vaccine within 4 weeks
  • Anyone with a compromised or weakened immune systems such as those receiving radiation, corticosteroids, or those with HIV/AIDS, cancer in the lymph, bone or blood systems
  • Pregnant women or those in close contact with a pregnant woman

结局指标

主要结局

To assess the effect of a pharmacist-driven immunization campaign on the rate of Zostavax immunizations in three separate community pharmacy settings

时间窗: 2 months

次要结局

  • To evaluate the relative efficacy of specific interventions on the rate of herpes zoster vaccinations(2 months)
  • To evaluate the perception of patients receiving the herpes zoster vaccination as to the role of pharmacists as immunizers(2 months)

研究者

申办方类型
Other

研究点 (6)

Loading locations...

相似试验